SECRETONEURIN
The missing link biomarker in cardiac testing
Welcome to CardiNor
– developing the missing link biomarker test for cardiovascular disease
– developing the missing link biomarker test for cardiovascular disease
CardiNor AS is a Norwegian biotech company recently established to handle the commercialization of Secretoneurin (SN), a new biomarker for cardiovascular disease (CVD).
Facts and figures
0
US cost on cardiovascular disease 3500 USD/sec.
0
One heart attac in US every 43 sec.
Latest news from CardiNor
Featured in CLI 31.10.2022:
Secretoneurin: a potential complementary cardiovascular biomarker
Secretoneurin is a novel prognostic biomarker that may predict mortality in heart failure and the occurrence of ventricular arrhythmias. Clinical Laboratory International (CLI) caught up with Professor Torbjørn Omland (University of Oslo, Oslo, Norway) to find out more about it.
Secretoneurin: a potential complementary cardiovascular biomarker